These results suggest that in addition to PSAT1, the hypermethylation of PHGDH can induce serine auxotrophy and that any tumor exhibiting high methylation of PHGDH or PSAT1 (and possibly PSPH) may be auxotrophic for serine and sensitive to therapies targeting serine availability. The gene discussed is PHGDH; the disease is neoplasm.